Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 35 member F5 (SLC35F5) is a predicted membrane-bound putative solute transporter, likely involved in the transmembrane transport of nucleotide sugars or related metabolites, as inferred by homology to other SLC35 family members. It shows expression across various tissues and may have a role in cellular metabolism or glycosylation. Although associated with certain rare inherited disorders (Seckel syndrome, Fanconi anemia), its precise physiological function and disease mechanisms remain poorly characterized. No drugs or clinical interventions are currently directed at SLC35F5, and there is no evidence that it serves as a biomarker or has unique safety liabilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member F5 (SLC35F5).